Homeopathic Drug Anthracinum Recalled Over Manufacturing Compliance Deviations
Washington Homeopathic Products is recalling Anthracinum liquid pellets due to manufacturing process deviations. The voluntary recall affects 219 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall with no reported illnesses or injuries. The hazard is manufacturing process deviations rather than known contamination or direct product harm, making it a precautionary recall.
Plain-English summary
Washington Homeopathic Products, Inc., located in Berkeley Springs, West Virginia, is recalling Anthracinum homeopathic liquid pellets in multiple potencies (6C, 7C, 8C, 9C, 12C, 14C, 30C, 200C, 11X, 14X, and 30X) due to Current Good Manufacturing Practice (cGMP) deviations.
The recall affects 219 glass amber bottles in lots 18415, 19369, 21577, 20308, and 20331. The product was distributed to consumers nationwide. This is a voluntary recall initiated by the manufacturer on May 13, 2022, and was terminated on May 25, 2023. The FDA classified this as a Class II recall on June 10, 2022.
No illnesses or injuries have been reported related to this product. Consumers who have purchased affected lots should stop using the product. For questions about whether you have a recalled product, contact your healthcare provider.
The recalled product
- Product
- Anthracinum, Potency: 6C, 7C, 8C, 9C, 12C, 14C, 30C, 200C, 11X, 14X, 30X Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawvermale Way Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot # 18415
- 19369
- 21577
- 20308
- 20331
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27